Apollo Therapeutics is a unique collaboration between three global pharmaceutical companies (GSK, J&J and AZ) and the technology transfer offices of Imperial College London, University College London and the University of Cambridge. This is the first time that three global pharmaceutical companies and the tech transfer offices of three world leading universities has come together to form a joint enterprise resulting in a truly innovative venture. Apollo will support translational research, shaping projects at an early stage to optimise discovery and delivery of new breakthrough treatments for onward development.